Clinical Trials
7 trialsNCT01587040 2022-04-19
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Sanofi
Phase 1/2 Completed
NCT01943838 2016-04-22
A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma
Sanofi
Phase 1 Completed
NCT00704392 2015-08-20
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors
Exelixis
Phase 1 Withdrawn
NCT01392924 2014-12-03
Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors
Sanofi
Phase 1 Completed
NCT00756847 2013-04-10
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Sanofi
Phase 1 Completed
NCT00486135 2013-02-01
Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma
Sanofi
Phase 1 Completed
NCT00692640 2012-03-23
Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors
Sanofi
Phase 1 Completed